Table 1 Cytokine levels in nasal fluid in healthy controls, NP and CRSsNP participants
IL-4 | IL-5 | IL-8 | IL-13 | Eotaxin | GM-CSF | RANTES | MCP-1 | MIP-1α | |
|---|---|---|---|---|---|---|---|---|---|
Controls | 7 0–32 | 5 1–238 | 1310 189–42,868 | 19 10–32 | 45 0–154 | 32 0–137 | 9 0–259 | 66 17–401 | 0 0–113 |
NP | 7 0–17 | 10 0–500 | 1851 0–265,037 | 10 4–62 | 75 0–422 | 27 0–112 | 14 0–563 | 117 13–3867 | 6 0–60 |
CRSsNP | 5 0–30 | 3 1–1831 | 1877 0–1,384,113 | 15 2–92 | 49 0–339 | 42 0–132 | 35 0–426 | 89 0–1676 | 0 0–673 |
P values | |||||||||
NP—Con | n.s. (0.822) | n.s. (0.070) | n.s. (0.562) | s. (< 0.001) | n.s. (0.114) | n.s. (0.286) | n.s. (0.447) | s. (< 0.001) | s. (< 0.001) |
CRSsNP—Con | n.s. (0.133) | n.s. (0.025)* | n.s. (0.291) | s. (< 0.01) | n.s. (0.361) | n.s. (0.456) | s. (< 0.050) | n.s. (0.028)* | n.s. (0.028)* |
NP—CRSsNP | n.s. (0.213) | s. (<0.001) | n.s. (0.887) | s. (< 0.01) | n.s. (0.315) | n.s. (0.148) | n.s. (0.079) | n.s. (0.024)* | n.s. (0.037)* |